UK's Smith+Nephew beats annual profit expectations
1. Smith+Nephew beat analysts' expectations for sales and profit. 2. US implant business recovery and cost cuts counter weak China demand.
1. Smith+Nephew beat analysts' expectations for sales and profit. 2. US implant business recovery and cost cuts counter weak China demand.
The earnings beat driven by strong US knee and hip implant business and cost cuts suggests robust near-term momentum. Similar past earnings surprises in the medical device sector have often resulted in immediate positive price reactions.
The strong annual performance and US market recovery are likely to influence investor sentiment and drive price action in the near term.
Earnings beats typically trigger immediate market reactions, as seen in previous instances in the sector.